Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-09 Purchase | 2023-06-21 10:57 am | Bionik Laboratories Corp. | BNKL | Matine Charles Director | 180,555 | $0.6 | $108,333 | 206,985 (Direct) | View |
| 2023-06-09 Purchase | 2023-06-21 10:57 am | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 180,555 | $0.6 | $108,333 | 1,876,127 (Indirect Direct) | View |
| 2023-06-09 Purchase | 2023-06-21 10:55 am | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 650,000 | $0.6 | $390,000 | 1,029,002 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-12-13 4:30 pm | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 135,560 | $0 | $0 | 1,479,450 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-04-01 12:22 pm | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Chairman | 95,149 | $0 | $0 | 319,624 (Indirect Direct) | View |
| 2021-03-29 Purchase | 2021-03-31 5:34 pm | Bionik Laboratories Corp. | BNKL | MARTIN JOSEPH R Director | 26,430 | $0 | $0 | 26,430 (Direct) | View |
| 2021-03-29 Purchase | 2021-03-31 3:51 pm | Bionik Laboratories Corp. | BNKL | Thevenon Audrey Director | 26,430 | $0 | $0 | 26,430 (Direct) | View |
| 2021-03-29 Purchase | 2021-03-31 3:50 pm | Bionik Laboratories Corp. | BNKL | Matine Charles Director | 26,430 | $0 | $0 | 26,430 (Direct) | View |
| 2021-03-29 Purchase | 2021-03-31 3:50 pm | Bionik Laboratories Corp. | BNKL | MALONE PETER GERALD Director | 26,430 | $0 | $0 | 26,430 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Conversion | 2023-06-21 10:59 am | N/A N/A | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 3,102,878 | $0.6 | 4,979,005 (Indirect) | View |
| 2023-06-13 Conversion | 2023-06-21 10:58 am | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 186,111 | $0.6 | 1,215,114 (Indirect) | View |
Ownership | 2022-10-25 11:27 am | 2021-10-14 2028-10-14 | Bionik Laboratories Corp. | BNKL | Gonsalves Daniel Executive Vice President & CFO | 0 | $0 | 85,000 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-13 1:17 pm | N/A 2029-10-06 | Bionik Laboratories Corp. | BNKL | Russo Richard Paul Jr CEO and President | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 7,500 | $3.16 | 442,883 (Indirect) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | 2020-07-26 2026-07-26 | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 59,378 | $0 | 442,883 (Direct) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 51,878 | $3.595 | 442,883 (Indirect) | View |
| 2022-03-31 Conversion | 2022-06-21 5:47 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 77,887 | $9.5 | 1,678,096 (Indirect) | View |
| 2021-07-15 Exercise | 2021-12-13 4:32 pm | 2020-07-26 2026-07-26 | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 120,759 | $0 | 1,661,465 (Direct) | View |
| 2021-03-29 Option Award | 2021-12-13 4:31 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 61,256 | $0 | 1,540,706 (Indirect) | View |
| 2021-10-14 Option Award | 2021-10-18 5:01 pm | N/A 2028-10-14 | Bionik Laboratories Corp. | BNKL | Wass Loren W. See Remarks | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-10-14 Option Award | 2021-10-15 5:02 pm | N/A 2028-10-14 | Bionik Laboratories Corp. | BNKL | Russo Richard Paul Jr CFO and Interim CEO | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2020-12-01 5:00 pm | 2021-11-30 2028-11-30 | Bionik Laboratories Corp. | BNKL | Russo Richard Paul Jr Chief Financial Officer | 0 | $0 | 76,902 (Direct) | View |
| 2019-11-25 Conversion | 2019-11-27 10:31 am | N/A N/A | Bionik Laboratories Corp. | BNKL | Gaston-Dreyfus Remi Director 10% Owner | 4,997 | $0 | 1,300,110 (Indirect) | View |